De Quervain Disease clinical trials

The registry lists 30 studies for De Quervain Disease across more than 10 countries. 7 are recruiting or about to start. 23 of them are mainly about De Quervain Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the De Quervain Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 16
Recruiting: 5
Terminated: 4
Status unknown: 3
Not yet recruiting: 2

Phase

Phase 4: 4
Phase 3: 1
Phase 2: 1

Where

United States: 7
Turkey: 6
Pakistan: 4
Egypt: 2
Taiwan: 2
United Kingdom: 1

Who runs them

Cairo University (3) · Yuzuncu Yıl University (2) · Muhammad Aamir Latif (1) · Massachusetts General Hospital (1) · University of California, Davis (1) · Riphah International University (1) · The University of Hong Kong (1) · Taipei Medical University Shuang Ho Hospital (1)

What is being tested here

Drugs under test in De Quervain Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	All
Triamcinolone	1	2
Ibuprofen	0	2
Acetaminophen	0	2
Triamcinolone Acetonide	0	1
Lidocaine	0	1
Oxycodone	0	1
Hydrocodone	0	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Jan 2027Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test · University of Texas at Austin
Jul 2027Ketorolac in Upper Extremity Tendinopathy and Arthropathy · Emory University

Who these studies take

Of the 5 De Quervain Disease studies recruiting now, 3 (60%) set no upper age limit and 2 (40%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 5
Age	Women	Men
10	0 (0%)	0 (0%)
18	5 (100%)	5 (100%)
30	5 (100%)	5 (100%)
40	5 (100%)	5 (100%)
50	5 (100%)	5 (100%)
65	5 (100%)	5 (100%)
75	4 (80%)	4 (80%)
85	3 (60%)	3 (60%)

Across all 30 studies, recruiting or not: 47% stop at 75 or younger and 33% at 65; 0% take children; 3% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long De Quervain Disease studies take

Of 16 interventional studies with no phase under De Quervain Disease, half reached primary completion within 13 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	13 mo2–28 · 16 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 30 of 30. search them.